glp-1 mayo clinic GLP-1s have continued to dominate the headlines. But are they everything we hoped for?⁣, ⁣, On this podcast episode of Health Matters, dietitian Tara Schmidt breaks down the biggest Companion Program for GLP-1s |

Documented symptomatic hypoglycemia (glucose of 70 mg/dL or less) was reported in 1.6% to 3.8% of patients receiving semaglutide injection vs

Electronic Medicines Compendium (EMC) SmPC repository

doi: 10.1096/fj.202201600R 89 HaagSMGulenMFReymondLGibelinAAbramiLDecoutAet al

Remote weight monitoring stands at the intersection of clinical efficiency and patient-centered care, offering benefits that include the following: Robust safety surveillance akin to trial protocols Early intervention capabilities for those at risk of adverse effects or non-response Enhanced patient experience through convenience and continuous support Opportunities for reimbursement that support practice growth and resource allocation Looking to the long term, remote weight monitoring sets the stage for sustained patient engagement and accountability, which are key drivers in preventing weight regain and ensuring ongoing success